FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francesco Schittulli

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Italy

Procedures

Physiology

Cell Divisions

Anatomy

Co-author Network

Publications

TOP 3
Patrizia Vici; Bruno Massidda; Marcella Mottolese; Francesco Schittulli; M Brandi; Giuseppe Colucci; A Di Benedetto; Luigi Di Lauro; Gianfranco Filippelli; Paolo Foggi; Nicola Gebbia; Diana Giannarelli; Francesco Giotta; Massimo Lopez
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.
Dino Amadori; Rosella Silvestrini; Mario De Lena; Francesco Boccardo; Andrea Rocca; Emanuela Scarpi; Francesco Schittulli; Mario Brandi; Roberta Maltoni; Patrizia Serra; Riccardo Ponzone; Nicoletta Biglia; Lorenzo Gianni; Amelia Tienghi; Maria Rosaria Valerio; Paola Bonginelli; Laura Amaducci; Marina Faedi; Editta Baldini; angelo paradiso
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Anna Crispo; Maurizio Montella; Maddalena Barba; Francesco Schittulli; Maria Rosaria De Marco; Maria Grimaldi; Michele Quaranta; Giuseppe Serravezza; Clementina Savastano; Gerardo Botti; Carlo La Vecchia; Giuseppe D'Aiuto
Association between mode of breast cancer detection and diagnosis delay.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francesco Schittulli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Patrizia Vici; Bruno Massidda; Marcella Mottolese; Francesco Schittulli; M Brandi; Giuseppe Colucci; A Di Benedetto; Luigi Di Lauro; Gianfranco Filippelli; Paolo Foggi; Nicola Gebbia; Diana Giannarelli; Francesco Giotta; Massimo Lopez
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(5):1121-9.
2011: Dino Amadori; Rosella Silvestrini; Mario De Lena; Francesco Boccardo; Andrea Rocca; Emanuela Scarpi; Francesco Schittulli; Mario Brandi; Roberta Maltoni; Patrizia Serra; Riccardo Ponzone; Nicoletta Biglia; Lorenzo Gianni; Amelia Tienghi; Maria Rosaria Valerio; Paola Bonginelli; Laura Amaducci; Marina Faedi; Editta Baldini; angelo paradiso
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Breast cancer research and treatment 2011;125(3):775-84.
2009: Anna Crispo; Maurizio Montella; Maddalena Barba; Francesco Schittulli; Maria Rosaria De Marco; Maria Grimaldi; Michele Quaranta; Giuseppe Serravezza; Clementina Savastano; Gerardo Botti; Carlo La Vecchia; Giuseppe D'Aiuto
Association between mode of breast cancer detection and diagnosis delay.
Breast (Edinburgh, Scotland) 2009;18(6):382-6.
2009: Yi Zhang; Anieta M Sieuwerts; Michelle McGreevy; Graham Casey; Tanja Cufer; angelo paradiso; Nadia Harbeck; Paul N Span; David G Hicks; Joseph Crowe; Raymond R Tubbs; G Thomas Budd; Joanne Lyons; Fred C G J Sweep; Manfred Schmitt; Francesco Schittulli; Rastko Golouh; Dmitri Talantov; Yixin Wang; John A Foekens
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
Breast cancer research and treatment 2009;116(2):303-9.
2009: Anita Mangia; Annalisa Chiriatti; Stefania Tommasi; F Menolascina; S Petroni; F A Zito; Giuseppina Simone; Francesco Schittulli; angelo paradiso
BRCA1 expression and molecular alterations in familial breast cancer.
Histology and histopathology 2009;24(1):69-76.
2008: Stefania Tommasi; Brunella Pilato; Rosamaria Pinto; Alessandro Monaco; Michele Bruno; Marco Campana; Maria Digennaro; Francesco Schittulli; Rosanna Lacalamita; angelo paradiso
Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Mutation research 2008;644(1-2):64-70.
2008: Antonia Bellizzi; Anita Mangia; Annalisa Chiriatti; S Petroni; Michele Quaranta; Francesco Schittulli; Andrea Malfettone; Rosa Angela Cardone; angelo paradiso; Stephan J Reshkin
RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease.
International journal of molecular medicine 2008;22(1):25-31.
2008: Anita Mangia; Patrizia Chiarappa; Stefania Tommasi; Annalisa Chiriatti; S Petroni; Francesco Schittulli; angelo paradiso
Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.
Cancer genetics and cytogenetics 2008;182(2):75-83.
2008: Francesco Schittulli
[Prevention and treatment of nausea and vomiting induced by chemotherapy. Introduction].
Tumori 2008;94(2):suppl 1-5.
2008: Ian Jonathan Seymour; Silvia Casadei; Valentina Zampiga; Simonetta Rosato; Rita Danesi; Fabio Falcini; Miria Strada; Nori Morini; Carlo Naldoni; angelo paradiso; Stefania Tommasi; Francesco Schittulli; Dino Amadori; Daniele Calistri
Disease family history and modification of breast cancer risk in common BRCA2 variants.
Oncology reports 2008;19(3):783-6.
2007: Michele Quaranta; Antonella Daniele; Maria Coviello; Maria Teresa Venneri; Ines Abbate; M E Caringella; S Di Tardo; R Divella; Paolo Trerotoli; M Di Gennaro; Francesco Schittulli; Emilia Fransvea; Gianluigi Giannelli
MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
Anticancer research 2007;27(5B):3593-600.
2007: Sabine Maier; Inko Nimmrich; Thomas Koenig; Serenella Eppenberger-Castori; Inga Bohlmann; angelo paradiso; Frédérique Spyratos; Christoph Thomssen; Volkmar Mueller; Jörg Nährig; Francesco Schittulli; Ronald Kates; Ralf Lesche; Ina Schwope; Antje Kluth; Almuth Marx; John Martens; John A Foekens; Manfred Schmitt; Nadia Harbeck
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1679-86.
2007: Stefania Tommasi; Anita Mangia; Rosanna Lacalamita; Antonia Bellizzi; Vita Fedele; Annalisa Chiriatti; Christoph Thomssen; Nancy Kendzierski; Agnese Latorre; Vito Lorusso; Francesco Schittulli; Francesco Alfredo Zito; Maria Kavallaris; angelo paradiso
Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins.
International journal of cancer. Journal international du cancer 2007;120(10):2078-85.
2007: Christina Yau; Vita Fedele; Ritu Roydasgupta; Jane Fridlyand; Alan Hubbard; Joe Gray; Karen L Chew; Shanaz H Dairkee; Dan H Moore; Francesco Schittulli; Stefania Tommasi; angelo paradiso; Donna G Albertson; Christopher C Benz
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Breast cancer research : BCR 2007;9(5):R59.
2007: Stefania Tommasi; Vita Fedele; Rosanna Lacalamita; Michele Bruno; Francesco Schittulli; David Ginzinger; Gery Scott; Serenella Eppenberger-Castori; Daniele Calistri; Silvia Casadei; Ian Seymour; Salvatore Longo; Gianluigi Giannelli; Brunella Pilato; Giuseppina Simone; Christopher C Benz; angelo paradiso
655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(3):241-8.
2006: Christopher C Benz; Vita Fedele; Fan Xu; Bauke Ylstra; David Ginzinger; Mamie Yu; Dan Moore; Rayna Kneuper Hall; Daynna J Wolff; Mary L Disis; Serenella Eppenberger-Castori; Urs Eppenberger; Francesco Schittulli; Stefania Tommasi; angelo paradiso; Gary K Scott; Donna G Albertson
Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers.
Genes, chromosomes & cancer 2006;45(11):983-94.
2006: Michele Quaranta; Antonella Daniele; Maria Coviello; Annalisa Savonarola; Ines Abbate; Maria Teresa Venneri; angelo paradiso; Baldassarre Stea; Alfredo Zito; Angela Labriola; Francesco Schittulli
c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.
Tumori 2006;92(4):311-7.
2006: John A Foekens; David Atkins; Yi Zhang; Fred C G J Sweep; Nadia Harbeck; angelo paradiso; Tanja Cufer; Anieta M Sieuwerts; Dmitri Talantov; Paul Span; Vivianne C G Tjan-Heijnen; Alfredo F Zito; Katja Specht; Heinz Hoefler; Rastko Golouh; Francesco Schittulli; Manfred Schmitt; Louk V A M Beex; Jan G M Klijn; Yixin Wang
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(11):1665-71.
2005: Stefania Tommasi; Antonella Crapolicchio; Rosanna Lacalamita; Michele Bruno; A Monaco; S Petroni; Francesco Schittulli; Salvatore Longo; M Digennaro; Daniele Calistri; Anita Mangia; angelo paradiso
BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
Mutation research 2005;578(1-2):395-405.
2005: Paola Parrella; Marina Scintu; Maria Prencipe; Maria Luana Poeta; Antonietta Pia Gallo; Carla Rabitti; Monica Rinaldi; Stefania Tommasi; angelo paradiso; Francesco Schittulli; Vanna Maria Valori; Salvatore Toma; Vittorio Altomare; Vito Michele Fazio
HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.
Cancer letters 2005;222(1):75-81.
2005: angelo paradiso; A Mangia; Annalisa Chiriatti; Stefania Tommasi; Alfredo Zito; A Latorre; Francesco Schittulli; Vito Lorusso
Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv14-19.
2004: Francesco Resta; Vincenzo Triggiani; Carlo Sabbà; Brunella Licchelli; Shahram Ghiyasaldin; Arcangelo Liso; Francesco Schittulli; M Quaranta; angelo paradiso; Emilio Tafaro; Edoardo Guastamacchia
The impact of body mass index and type 2 diabetes on breast cancer: current therapeutic measures of prevention.
Current drug targets. Immune, endocrine and metabolic disorders 2004;4(4):327-33.
2004: Annalisa Volpi; Francesco Bacci; angelo paradiso; Luca Saragoni; Emanuela Scarpi; Monica Ricci; Mirella Aldi; Simonetta Bianchi; Pietro Muretto; Fiorella Nuzzo; Giuseppina Simone; Anita Mangia; Francesco Schittulli; Dino Amadori
Prognostic relevance of histological grade and its components in node-negative breast cancer patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(9):1038-44.
2004: Paola Parrella; Maria Luana Poeta; Antonietta Pia Gallo; Maria Prencipe; Marina Scintu; Adolfo Apicella; Raffaele Rossiello; Giuseppina Liguoro; Davide Seripa; Carolina Gravina; Carla Rabitti; Monica Rinaldi; Theresa L Nicol; Stefania Tommasi; angelo paradiso; Francesco Schittulli; Vittorio Altomare; Vito Michele Fazio
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5349-54.
2004: angelo paradiso; Michele Bruno; Onofrio Cicoria; Maria Digennaro; Salvatore Longo; Michele Rinaldi; Francesco Schittulli
Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: a hospital-based population study.
Tumori 2004;90(4):435-6.
2004: Gianluigi Giannelli; Roberta Erriquez; Emilia Fransvea; Antonella Daniele; Paolo Trerotoli; Francesco Schittulli; Maria Grano; Michele Quaranta; Salvatore Antonaci
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.
International journal of cancer. Journal international du cancer 2004;109(5):782-5.
2004: Michele Quaranta; Maria Coviello; Antonella Daniele; Ines Abbate; L G Durrant; angelo paradiso; Francesco Schittulli
MUC3 and MCA serum levels and steroid receptor content in breast cancer.
The International journal of biological markers 2004;19(2):109-14.
2004: Mario Brandi; Patrizia Vici; Massimo Lopez; Maria Rosaria Valerio; Francesco Giotta; Nicola Gebbia; Francesco Schittulli; Giuseppe Colucci
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study.
Seminars in oncology 2004;31(2 Suppl 5):13-9.
2004: Michele Bruno; Stefania Tommasi; Baldassarre Stea; M Quaranta; Francesco Schittulli; A Mastropasqua; Alessandro Distante; L Di Paola; angelo paradiso
Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 1():I48-I54.
2004: Giovanna Cipollini; Stefania Tommasi; angelo paradiso; Paolo Aretini; F Bonatti; Isa Maura Brunetti; Michele Bruno; Grazia Lombardi; Francesco Schittulli; Elisa Sensi; Mariella Tancredi; Generoso Bevilacqua; Maria Adelaide Caligo
Genetic alterations in hereditary breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 1():I7-I13.
2003: Laura Medri; Annalisa Volpi; Oriana Nanni; Anna Maria Vecci; Anita Mangia; Francesco Schittulli; Franco Padovani; Donata Casadei Giunchi; Alfredo Zito; Alfredo Vito; Dino Amadori; angelo paradiso; Rosella Silvestrini
Prognostic relevance of mitotic activity in patients with node-negative breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(11):1067-75.
2003: Lucia Giordani; Paolo Bruzzi; Carla Lasalandra; Michele Quaranta; Francesco Schittulli; Fulvio Della Ragione; Achille Iolascon
Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes.
Clinical chemistry 2003;49(10):1664-7.
2003: Edoardo Guastamacchia; Francesco Resta; Anita Mangia; Francesco Schittulli; Anna Ciampolillo; Vincenzo Triggiani; Brunella Licchelli; angelo paradiso; Carlo Sabbà; Emilio Tafaro
Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets.
Current drug targets. Immune, endocrine and metabolic disorders 2003;3(3):205-9.
2003: Annalisa Volpi; Oriana Nanni; Franca De Paola; Anna Maria Granato; Anita Mangia; Franco Monti; Francesco Schittulli; Mario De Lena; Emanuela Scarpi; Paola Rosetti; Manlio Monti; Lorenzo Gianni; Dino Amadori; angelo paradiso
HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2708-12.
2003: Vito Lorusso; Enrico Crucitta; Nicola Silvestris; Annamaria Catino; L Caporusso; A Mazzei; Michele Guida; Agnese Latorre; Domenico Sambiasi; C D'Amico; Francesco Schittulli; Pietro Calabrese; Mario De Lena
Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.
British journal of cancer 2003;88(4):491-5.
2003: G Gargano; Mario De Lena; F Zito; G Fanizza; Vittorio Mattioli; Francesco Schittulli
Ovarian fibroma: our experience of 34 cases.
European journal of gynaecological oncology 2003;24(5):429-32.
2002: Anita Mangia; Stefania Tommasi; Stephan J Reshkin; Giuseppina Simone; Baldassarre Stea; Francesco Schittulli; angelo paradiso
Gonadotropin releasing hormone receptor expression in primary breast cancer: comparison of immunohistochemical, radioligand and Western blot analyses.
Oncology reports 2002;9(5):1127-32.
2001: angelo paradiso; Francesco Schittulli; G Cellamare; Anita Mangia; Franco Marzullo; Vito Lorusso; Mario De Lena
Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3929-37.
2001: angelo paradiso; Girolamo Ranieri; Nicola Silvestris; G Naccarato; G Bevilacqua; Anita Mangia; B Leone; C Vallejo; Giuseppina Simone; Francesco Schittulli; Mario De Lena
Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis.
Clinical and experimental medicine 2001;1(3):127-32.
2001: angelo paradiso; G Serio; M Fanelli; Anita Mangia; G Cellamare; Francesco Schittulli
Predictability of monthly and yearly rhythms of breast cancer features.
Breast cancer research and treatment 2001;67(1):41-9.
2000: angelo paradiso; A Pezzetta; G Cellamare; Francesco Schittulli; Franco Marzullo; Stephan J Reshkin
GnRH receptors in human breast cancer and its contiguous not-involved breast tissue.
Journal of endocrinological investigation 2000;23(2):90-6.
1999: angelo paradiso; Stefania Tommasi; A Barletta; Bernardo A Leone; Juan A Lacava; C Vellejo; Angela Labriola; Franco Marzullo; R Altieri; Francesco Schittulli; Mario De Lena
Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients.
Anticancer research 1999;19(5C):4523-8.
1998: Anita Mangia; Mario De Lena; A Barletta; Franco Marzullo; M Attolico; Baldassarre Stea; S Petroni; Angela Labriola; G Cellamare; G Digiesi; R Altieri; Francesco Schittulli; angelo paradiso
Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome.
Journal of experimental & clinical cancer research : CR 1998;17(3):317-23.
1998: Vito Lorusso; Annamaria Catino; Francesco Schittulli; Salvatore Longo; A Racanelli; Artur Timurian; Franco Marzullo; Giuseppina Simone; M Brandi; Mario De Lena
Neoadjuvant chemotherapy with accelerated CNF plus G-CSF in patients with breast cancer tumors larger than three centimeters: a pilot study.
International journal of oncology 1998;12(5):1177-81.
1997: C Giannella; F A Zito; F Colonna; angelo paradiso; Franco Marzullo; Mauro Alaibac; Francesco Schittulli
Comparison of formalin, ethanol, and Histochoice fixation on the PCR amplification from paraffin-embedded breast cancer tissue.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1997;35(8):633-5.
1997: Mauro Alaibac; M Congedo; G Barbarossa; A Bottiglieri; E D Fillippi; Franco Marzullo; G Quarta; Francesco Schittulli
Analysis of clonal antigen receptor gene rearrangements in T-cells involved with Kaposi's sarcoma.
Anticancer research 1997;17(2A):1205-7.
1996: Mario De Lena; A Barletta; Franco Marzullo; M Rabinovich; Bernardo A Leone; Carlos T Vallejo; Mario R Machiavelli; A Romero; J Perez; Juan A Lacava; M A Cuevas; R Rodriguez; Francesco Schittulli; A Paradisco
Nuclear grade and DNA ploidy in stage IV breast cancer with only visceral metastases at initial diagnosis.
Tumori 1996;82(4):386-9.
1996: Giuseppina Simone; Anita Mangia; S Petroni; Franco Marzullo; angelo paradiso; Francesco Schittulli
[Dna synthesis and expression of steroid receptors in cells of human breast carcinoma].
Pathologica 1996;88(2):111-6.
1996: C Rella; M Coviello; Francesco Giotta; Evaristo Maiello; P Colavito; D Colangelo; M Quaranta; Giuseppe Colucci; Francesco Schittulli
A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.
Breast cancer research and treatment 1996;40(2):151-9.
1996: Franco Marzullo; F A Zito; A Marzullo; Angela Labriola; Francesco Schittulli; G Gargano; R De Girolamo; F Colonna
Infiltrating cribriform carcinoma of the breast. A clinico-pathologic and immunohistochemical study of 5 cases.
European journal of gynaecological oncology 1996;17(3):228-31.
1996: Ines Abbate; M D Musci; angelo paradiso; Francesco Schittulli; Mario Correale
Determination of free PSA in breast cancer cytosols by IRMA.
The International journal of biological markers 1996;11(1):53-4.
1996: Mario Correale; Arcangelo Pagliarulo; G Donatuti; F Sturdà; A M Capobianco; V Stigliani; M Rizzello; S Circhietta; F Pignatelli; L Leone; Vincenzo Frusciante; Sergio Modoni; Francesco Schittulli
Preliminary clinical evaluation of free/total PSA ratio by the IMMULITE system.
The International journal of biological markers 1996;11(1):24-8.
1995: angelo paradiso; Anita Mangia; A Barletta; Saverio Fusilli; Franco Marzullo; Francesco Schittulli; Mario De Lena
Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects.
European journal of cancer (Oxford, England : 1990) 1995;31A(6):911-6.
1995: A Donadeo; G Micelli; M Quaranta; A Atlante; Francesco Schittulli
MCA performance in preoperative breast cancer patients.
Anticancer research 1995;15(2):527-9.
1994: angelo paradiso; M G Vetrugno; G Capuano; S Longo; L Sibilano; Francesco Schittulli; Mario Correale; A Barletta; G Pelagio; Mario De Lena
Expression of GST-mu transferase in breast cancer patients and healthy controls.
The International journal of biological markers 1994;9(4):219-23.
1994: Mario Correale; T Tedone; Ines Abbate; P Zotti; A Nassi; angelo paradiso; Francesco Schittulli; Mario De Lena
TPA-cyk assay in cytosol from primary breast cancer: preliminary results.
The International journal of biological markers 1994;9(4):264-5.
1993: angelo paradiso; Anita Mangia; A Barletta; Franco Marzullo; V Ventrella; A Racanelli; Francesco Schittulli; Mario De Lena
Mammography and morphobiologic characteristics of human breast cancer.
Tumori 1993;79(6):422-6.
1993: angelo paradiso; V Ventrella; G Farchi; S Tommasi; Anita Mangia; A Barletta; Francesco Schittulli; A Racanelli; Mario De Lena
Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer.
Oncology 1993;50(2):104-9.
1993: Mario Correale; angelo paradiso; Ines Abbate; Anita Mangia; C D Dragone; T Tedone; R Filotico; Francesco Schittulli; Mario De Lena
Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activity.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1993;14(1):30-7.
1993: Mario Correale; Ines Abbate; angelo paradiso; Francesco Schittulli; C D Dragone; T Tedone; G Gargano; Annamaria Catino; M D Musci; Mario De Lena
pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer.
Cell biophysics 1993;22(1-3):101-10.
1993: angelo paradiso; Anita Mangia; A Barletta; Annamaria Catino; A Giannuzzi; Francesco Schittulli; N Radogna; S Longo; D Palmieri; Franco Marzullo
Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer.
Drugs 1993;45 Suppl 2():68-74; discussion 73-4.
1992: S Tommasi; C Giannella; angelo paradiso; A Barletta; Anita Mangia; Giuseppina Simone; A T Primavera; V Albarani; Francesco Schittulli; S Longo
HER-2/neu gene in primary and local metastatic axillary lymph nodes in human breast tumors.
The International journal of biological markers 1992;7(2):107-13.
1990: M Quaranta; G Micelli; M Coviello; A Donadeo; A Lozupone; Francesco Schittulli
[Clinical usefulness of CA M26 and CA M29 in breast carcinoma].
The Journal of nuclear medicine and allied sciences 1990;34(4 Suppl):35-8.
1990: V Ventrella; angelo paradiso; G Farchi; S Tommasi; Francesco Schittulli; A Racanelli; Mario De Lena
[The relationship between the receptor status and the mammographic picture in operable breast cancer].
La Radiologia medica 1990;79(5):483-8.
1990: Mario De Lena; S Tommasi; Francesco Schittulli; Vito Lorusso; angelo paradiso
Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study.
Tumori 1990;76(2):190-5.
1988: angelo paradiso; Vito Lorusso; S Tommasi; Francesco Schittulli; Evaristo Maiello; Mario De Lena
Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer.
Breast cancer research and treatment 1988;11(1):31-6.
1987: M Quaranta; G Micelli; M Coviello; Ines Abbate; Francesco Schittulli; D D'Errico; D Palmieri
[Control study of bacterial infections in patients with carcinoma of the breast subjected to radical mastectomy].
Quaderni Sclavo di diagnostica clinica e di laboratorio 1987;23(2):176-83.
1987: Giuseppina Simone; angelo paradiso; Angela Labriola; S Petroni; S Tommasi; Francesco Schittulli
[Receptor correlation between histochemical and biochemical methods in advanced breast carcinoma].
Pathologica 1987;79(1059-1060):113-8.